Impact of astroglial connexins on modafinil pharmacological properties A Duchêne, M Perier, Y Zhao, X Liu, J Thomasson, F Chauveau, ... Sleep 39 (6), 1283-1292, 2016 | 60 | 2016 |
Antidepressants impact connexin 43 channel functions in astrocytes T Jeanson, A Pondaven, P Ezan, F Mouthon, M Charvériat, C Giaume Frontiers in cellular neuroscience 9, 495, 2016 | 60 | 2016 |
Connexin-dependent neuroglial networking as a new therapeutic target M Charvériat, CC Naus, L Leybaert, JC Sáez, C Giaume Frontiers in Cellular Neuroscience 11, 174, 2017 | 54 | 2017 |
Human connexin channel specificity of classical and new gap junction inhibitors C Picoli, V Nouvel, F Aubry, M Reboul, A Duchêne, T Jeanson, ... Journal of biomolecular screening 17 (10), 1339-1347, 2012 | 40 | 2012 |
Potentiation of amitriptyline anti-hyperalgesic-like action by astroglial connexin 43 inhibition in neuropathic rats T Jeanson, A Duchêne, D Richard, S Bourgoin, C Picoli, P Ezan, ... Scientific Reports 6 (1), 38766, 2016 | 32 | 2016 |
Use of anti-connexin agents for modulating the therapeutic effect of psychotropic drugs F Mouthon, M Charveriat, JP Deslys, F Iris US Patent App. 13/063,409, 2011 | 30 | 2011 |
Dissociated features of social cognition altered in mouse models of schizophrenia: Focus on social dominance and acoustic communication A Faure, A Nosjean, E Pittaras, A Duchêne, A Andrieux, S Gory-Fauré, ... Neuropharmacology 159, 107334, 2019 | 19 | 2019 |
Efficacy of THN102 (a combination of modafinil and flecainide) on vigilance and cognition during 40‐hour total sleep deprivation in healthy subjects: Glial connexins as a … F Sauvet, M Erblang, D Gomez‐Merino, A Rabat, M Guillard, ... British journal of clinical pharmacology 85 (11), 2623-2633, 2019 | 19 | 2019 |
High-content screening identifies new inhibitors of connexin 43 gap junctions C Picoli, E Soleilhac, A Journet, C Barette, M Comte, C Giaume, ... ASSAY and Drug Development Technologies 17 (5), 240-248, 2019 | 19 | 2019 |
Cortico-amygdala-striatal activation by modafinil/flecainide combination D Vodovar, A Duchêne, C Wimberley, C Leroy, G Pottier, Y Dauvilliers, ... International Journal of Neuropsychopharmacology 21 (7), 687-696, 2018 | 19 | 2018 |
New inhibitors of prion replication that target the amyloid precursor M Charveriat, M Reboul, Q Wang, C Picoli, N Lenuzza, A Montagnac, ... Journal of general virology 90 (5), 1294-1301, 2009 | 19 | 2009 |
Functional ultrasound imaging to study brain dynamics: application of pharmaco-fUS to atomoxetine B Vidal, M Droguerre, L Venet, L Zimmer, M Valdebenito, F Mouthon, ... Neuropharmacology 179, 108273, 2020 | 17 | 2020 |
Pharmaco-fUS for characterizing drugs for Alzheimer’s disease–the case of THN201, a drug combination of donepezil plus Mefloquine B Vidal, M Droguerre, M Valdebenito, L Zimmer, M Hamon, F Mouthon, ... Frontiers in Neuroscience 14, 835, 2020 | 15 | 2020 |
Efficacy of THN201, a combination of donepezil and mefloquine, to reverse neurocognitive deficits in Alzheimer’s disease M Droguerre, A Duchêne, C Picoli, B Portal, C Lejards, BP Guiard, ... Frontiers in neuroscience 14, 563, 2020 | 15 | 2020 |
Connexins as therapeutic targets in neurological and neuropsychiatric disorders M Charvériat, F Mouthon, W Rein, A Verkhratsky Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1867 (5), 166098, 2021 | 14 | 2021 |
A New Tool for In Vivo Study of Astrocyte Connexin 43 in Brain M Droguerre, T Tsurugizawa, A Duchêne, B Portal, BP Guiard, N Déglon, ... Scientific reports 9 (1), 18292, 2019 | 14 | 2019 |
Innovative approaches in CNS drug discovery M Charveriat, V Lafon, F Mouthon, L Zimmer Therapies 76 (2), 101-109, 2021 | 10 | 2021 |
Modeling and targeting neuroglial interactions with human pluripotent stem cell models J Bigarreau, N Rouach, AL Perrier, F Mouthon, M Charvériat International Journal of Molecular Sciences 23 (3), 1684, 2022 | 8 | 2022 |
Evaluating and modulating TFEB in the control of autophagy: toward new treatments in CNS disorders A da Costa, T Metais, F Mouthon, D Kerkovich, M Charvériat Fundamental & clinical pharmacology 35 (3), 539-551, 2021 | 8 | 2021 |
Clinical pharmacology: Current innovations and future challenges JL Cracowski, JS Hulot, S Laporte, M Charvériat, M Roustit, D Deplanque, ... Fundamental & Clinical Pharmacology 36 (3), 456-467, 2022 | 6 | 2022 |